RecruitingPhase 4NCT06962306

Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery

Perioperative Methadone Use for Cleft Palate Repair: A Randomized Controlled Trial


Sponsor

Duke University

Enrollment

60 participants

Start Date

Jun 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following cleft palate surgery in infants and young children.


Eligibility

Min Age: 6 MonthsMax Age: 4 Years

Inclusion Criteria3

  • Age 6 months to 4 years of age
  • Primary cleft palate repair
  • Signed informed consent by parent or legal guardian

Exclusion Criteria4

  • History of chronic kidney or liver disease
  • Planned admission to the Pediatric Intensive Care Unit (PICU)
  • Additional procedures under general anesthesia for which opioids would be prescribed
  • Any patient ineligible for study participation at the discretion of the investigators

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethadone hydrochloride

Initial dosing 0.2mg/kg, potential to escalate to 0.25mg/kg following interim analysis

DRUGFentanyl/Hydromorphone

Per routine care


Locations(1)

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06962306


Related Trials